Glaxosmithkline Pharmaceuticals announces change in senior management
With effect from 08 July 2024
Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Executive Vice President - Medical Affairs, effective 8 July 2024. She will be part of the Senior Management team of the Company.Further, Dr. Rashmi Hegde, current Executive Vice President - Medical Affairs would retire w.e.f 31 July 2024.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content